ArticleAngewandte Chemie (International ed. in English)2026
Molecular Conformation-Locking for Eye Care and Highly Efficient Narrowband Deep-Blue Organic Electroluminescence.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The advancement of high-color-purity displays demands deep-blue emitters that fulfil stringent colorimetric standards while minimizing photobiological risks to eye health. We propose a skeletal rigidity strategy by fusing a five-membered oxa-heterocycle into a classical MR-TADF skeleton (ν-DABNA), which simultaneously introduces rigidity enhancement via aromatic fusion and conformational locking. This approach resulted in an increased optical bandgap and the formation of intramolecular C-H···O secondary interactions, and thus a systematic blue-shift and narrowing emission spectrum. In toluene solution, the proof-of-concept molecule, v-DABNA-O, exhibits a narrowband deep-blue emission peaking at 460.4 nm, with an ultra-narrow full-width at half maximum (FWHM) of 12.0/69.8 nm/meV. As a result, the ν-DABNA-based device with a sensitizer achieves a maximum external quantum efficiency of 36.1%, a narrow electroluminescence spectrum with an FWHM of 17.9/95.4 nm/meV, and a Commission Internationale de l'Éclairage coordinate of (0.135, 0.091). Crucially, the device achieves a sharp suppression of high-energy emission below 450 nm, directly addressing the imperative for visual safety. This work successfully addresses the trilemma in deep-blue emitters by simultaneously achieving an ultra-narrow emission bandwidth, a precisely positioned emission peak, and suppressed spectral intensity below 450 nm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.